Prima Nexus / News / Events & workshops

Prima Nexus supported the 15th Asian Conference on Transcription and two more conferences in August 2017

Scientists working on transcription, gene regulation and RNA biology met in Penang for ACT-XV, and in mid-August proteomics researchers met in Kuala Lumpur and young chemists in Penang. Prima Nexus supported all three conferences.

· Events & workshops

Three delegates pose with props in front of the Prima Nexus backdrop
Delegates at the Prima Nexus photo booth during ACT-XV, the 15th Asian Conference on Transcription, Jen Hotel, Penang, 1 August 2017.

From the Prima Nexus archive: a look back at July and August 2017.

Prima Nexus supported the 15th Asian Conference on Transcription (ACT-XV), held at the Jen Hotel, Penang, from 31 July to 4 August 2017 and organised by the ACT committees and the School of Biological Sciences, Universiti Sains Malaysia (USM). In mid-August it also supported the International Proteomics Conference 2017 (IPC2017) in Kuala Lumpur, from 15 to 17 August, and the 6th International Conference for Young Chemists (ICYC2017) in Penang, from 16 to 18 August.

An Asian meeting on transcription

The Asian Conference on Transcription began in Taipei in 1990, set up by five senior scientists as a forum where Asian researchers could share their findings and build links across the region. Malaysia had hosted it once before, in Kuala Lumpur in 2002. The 2017 programme covered transcription, gene regulation, post-transcriptional regulation, RNA biology, applied transcription, advanced technology in transcriptional analysis and systems integration.

Keynotes, speakers and posters

The keynote speakers were Professor Frans J. de Bruijn of the National Institute for Agricultural Research, France, and Professor Stephen Lory of Harvard Medical School, USA. Featured speakers came from Malaysia, Taiwan, Singapore, China, Korea, New Zealand, Thailand and the USA, and research posters were on display. On 1 August, Prima Nexus was on site with a stand and a photo booth, where delegates had their picture taken in front of a Prima Nexus backdrop.

A speaker at the lectern addresses delegates seated at long tables in the conference hall
A speaker addresses delegates in the conference hall at the Jen Hotel, Penang, during ACT-XV.

Proteomics in Kuala Lumpur and young chemists in Penang

The Malaysian Agricultural Proteomics Society (MAPS) held IPC2017 at the UNMC Kuala Lumpur Teaching Centre in Chulan Tower from 15 to 17 August, and the School of Chemical Sciences at USM held ICYC2017 at St Giles The Wembley Hotel, Penang, from 16 to 18 August. Prima Nexus supported all three conferences. More photos of ACT-XV are on the conference's event page, and how Prima Nexus supports research teams today, from genomics to proteomics, is set out on our research platforms page.

About Prima Nexus

Founded in 2014, Prima Nexus Sdn Bhd is a Malaysian research, scientific consulting and integrated research support company advancing scientific discovery and healthcare innovation. We provide end-to-end research solutions, from early-stage discovery and experimental design to cell-based studies, preclinical animal testing, clinical trials and commercialization. Our multidisciplinary expertise spans genomics, genetic applications, proteomics, molecular biology, stem cell research, bioinformatics and clinical research. Through strategic collaborations with universities, research institutions, industry and global technology partners, we connect scientific expertise and advanced technologies to accelerate research into real-world applications. Our collaborations have supported more than 150 papers in peer-reviewed journals and research teams at more than 40 institutions across Malaysia. More about Prima Nexus.

Media and partnership enquiries

Prima Nexus Sdn Bhd, Level 2, Mercu Aspire, 59200 KL Eco City, Kuala Lumpur, Malaysia. Email info@primanexus.com.my or WhatsApp 017-305 1076.

TranscriptionGene regulationProteomicsChemistryConferenceCollaboration2017
Share: LinkedIn WhatsApp Facebook X Email

Work with us

Have a study in mind? Tell us what you're trying to discover.

From a single biomarker panel to a multi-site clinical programme, we assemble the platform, assign you one project lead, and stay accountable to your result.